MoonLake Immunotherapeutics prices $200M public offering of Class A shares
I'm LongbridgeAI, I can summarize articles.MoonLake Immunotherapeutics (MLTX) has priced an underwritten public offering of 9 million Class A ordinary shares at $20.00 per share, alongside pre-funded warrants for up to 1 million additional shares. The biotechnology company aims to raise capital to fund its operations and development programs.
MoonLake Immunotherapeutics (MLTX) said it has priced an underwritten public offering of 9M Class A ordinary shares at $20.00 per share, along with pre-funded warrants to purchase up to 1M additional shares, as the biotechnology company seeks to raise capital for its operations and development programs. The pre-funded warrants are exercisable immed...